Abstract: The present disclosure relates to compositions and methods that enable the formation of pharmaceutically relevant particles that can be used for therapy. In particular, the methods disclosed herein allow the controlled formation of circular particles having low internal void spaces comprising bioactive therapeutic agents.

Abstract: The present disclosure relates to methods that enable the continuous formation of droplets and dehydration of droplets to provide pharmaceutically relevant particles that can be used for therapy. In particular, the methods disclosed herein allow the controlled continuous droplet formation and dehydration that produce circular particles having low internal void spaces comprising bioactive therapeutic biologies.

Abstract: The present disclosure relates to compositions and methods that enable the formation of pharmaceutically relevant particles that can be used for therapy. In particular, the methods disclosed herein allow the controlled formation of circular particles having low internal void spaces comprising bioactive therapeutic biologies.

Abstract: One embodiment of a shielded cable assembly as disclosed herein includes a connector body including a wire attachment region. A contact member, including a wire attachment portion, is mounted on the connector body with the wire attachment portion positioned adjacent to the wire attachment region of the connector body. An insulating insert, including a wire-receiving region, is positioned adjacent to the connector body with at least a portion of the wire attachment region of the connector body extending into the wire-receiving region. A wire of a cable extends into the wire-receiving region of the insulating insert and is electrically connected to the wire attachment portion of the contact member. A shielding body, including an insert-receiving region, has at least a portion of the insulating insert positioned in the insert-receiving region. An insulating cover covers at least a portion of the shielding body.

Abstract: One embodiment of a shielded cable assembly as disclosed herein includes a connector body including a wire attachment region. A contact member, including a wire attachment portion, is mounted on the connector body with the wire attachment portion positioned adjacent to the wire attachment region of the connector body. An insulating insert, including a wire-receiving region, is positioned adjacent to the connector body with at least a portion of the wire attachment region of the connector body extending into the wire-receiving region. A wire of a cable extends into the wire-receiving region of the insulating insert and is electrically connected to the wire attachment portion of the contact member. A shielding body, including an insert-receiving region, has at least a portion of the insulating insert positioned in the insert-receiving region. An insulating cover covers at least a portion of the shielding body.